UK-CAB 30 – Testing
Friday 31 July 2009
Testing
At the MRC Clinical Trials Unit, 222 Euston Road, London, NW1
Programme
09:30 – 10:00 | Registration, refreshments and expenses |
10:00 – 10:15 | Welcome and UKCAB updates – Michael Marr |
10:15 – 11:00 | BHIVA Routine Monitoring Guidelines – Matt Williams |
11:00 – 11:15 | Break |
11:15 – 12:15 | HIV Treatment Advocacy Overview
|
12.15 – 12.30 | Pre-Meeting for BMS – Simon Collins |
12:30 – 14:00 | Lunch |
14:00 – 15:15 | Company meeting: BMS |
15:15 – 15:30 | Break |
15:30 – 16:00 | Conference Feedback & UKCAB AOB – Simon Collins |
16:00 | Close |
Background Reading
Incomplete Peripheral CD4+ Cell Count Restoration in HIV-Infected Patients Receiving Long-Term Antiretroviral Treatment.
Download as a PDF file [416 Kb]
Denver Principles
http://en.wikipedia.org/wiki/People_With_AIDS#The_Denver_Principles
The Early AIDS Epidemic in the US: Views from Atlanta and Hollywood Harold Jaffe Univ of Oxford, UK
http://www.retroconference.org/2008/data/files/retro2008_frameset.html
Scottish Independent Advocacy Alliance
http://www.siaa.org.uk/images/stories/siaaprinciples%26standardsforweb.pdf
http://www.ncbi.nlm.nih.gov/pubmed/19496633?log$=activity
http://www.hivinsite.com/insite?page=hmq-0810-04
http://www.avert.org/aids-history-86.htm
Financial support
The UK-CAB receives unrestricted funding from some pharmaceutical companies towards the direct costs of holding four meetings each year. This funding supports the travel and accommodation costs for members to attend from outside London, plus the cost of catering.
The content, programme and agenda for meetings is decided by the UK-CAB steering group in consultation with the wider membership. Funding is unconnected to meeting content.
We believe that manufacturers who currently develop and market medicines have a responsibility to actively engage with advocacy organisations and that HIV positive people and their advocates should be able to directly question manufacturers about the safety and efficacy of their products and proposals for future research.
For a list of companies that support the UK-CAB please see the “about us” page.